Compare Repligen Corporation Common Stock (RGEN) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Western Union Co — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B), while Western Union Co trades at $6.05 (market cap $1.90B). The key difference: Repligen Corporation Common Stock is far larger — about 6× Western Union Co's market cap, and Western Union Co pays a 15.41% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Western Union Co for 96 Days on average.
| RGEN | WU | |
|---|---|---|
Market Cap | $11.31B | $1.90B |
Volume | 1,216,919 | 6,506,793 |
Sector | Health | Financials |
52-Week High | $194.57 | $10.28 |
52-Week Low | $102.87 | $5.90 |
Typical Hold Time | 0 Days | 96 Days |
Enterprise Value | $11.20B | $1.81B |
Dividend Yield | — | 15.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Western Union (WU) trades at $6.10, down 0.16% with a bearish technical outlook. The stock shows attractive valuation metrics including a P/E of 4.92 and P/S of 0.48, while maintaining strong profitability with 35.09% gross margins and 43.97% ROE. Recent earnings show mixed performance with two misses in the last three quarters. The company is implementing a $200 million cost-cutting plan and expanding retail partnerships while navigating regulatory approval for its Intermex acquisition.
WU presents a value opportunity with deep discount valuation but faces execution risks. The turnaround strategy and digital transformation offer potential upside if successful, though recent earnings volatility and competitive pressures warrant caution. Analyst consensus is mixed with a $6.71 price target representing 10% upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
